Clinical Trials Logo
  1. Home
  2. Substance Use Disorders
  3. NCT05731102
  4. Details
NCT05731102 Clinical Trial

Diagnostic Survey of Mental and Substance Use Disorders Among Norwegian College and University Students

Substance Use Disorders Clinical Trial

Official title:
Students' Health and Wellbeing Study (SHOT) 2022

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT05731102
Other study ID # PDB1841
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 24, 2023
Est. completion date February 20, 2023

Study information
Verified date November 2023
Source Norwegian Institute of Public Health
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aims of this observational survey are to 1) collect data on the prevalence of mental and substance use disorders, and 2) investigate risk factors and consequences of mental and substance use disorder

Description:

This project focuses on mental health, quality of life and alcohol and substance use in students pursuing higher education. The targeted population, all Norwegian college and university students, are in an important and vulnerable period of life transitions. The overall aim of the current project is two-fold: First, the investigators will conduct a clinical assessment of mental disorders by using the newly developed electronic version of the World Health Organization (WHO) Composite International Diagnostic Interview, fifth version (CIDI 5.0), developed for the WHO World Mental Health Surveys. CIDI 5.0 is a standardized interview assessing 30-days,12 months and lifetime prevalence for several mental and substance use disorders according to diagnostic criteria in the Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM-5) and International Classification of Diseases 10th edition (ICD-10). The overall aim of this will be to obtain accurate prevalence rates of disorders, as well as to validate and compare the briefer instrument used in the Students' Health and Wellbeing Study (SHOT), including the Hopkins Symptom Checklist-25 (HSCL-25). Second, the investigators will examine risk factors based on data from the SHoT, which is one of the world's largest epidemiological studies of student health.

Recruitment information / eligibility
Status Completed
Enrollment 9585
Est. completion date February 20, 2023
Est. primary completion date February 20, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - Being a fulltime college or university student - Norwegian citizenship - Ages 18-35 years - Sufficient understanding of Norwegian or English to conduct the interview Exclusion Criteria: - None

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• Electronic version of the Composite International Diagnostic Interview 5th version (E-CIDI 5.0)
Observational study assessing prevalence of mental and substance use disorders among college and university students

Locations
Country Name City State
Norway Norwegian Institute of Public Health Bergen

Sponsors (3)
Lead Sponsor Collaborator
Norwegian Institute of Public Health Society of Interventional Oncology, Statistics Norway

Country where clinical trial is conducted

Norway, 

References & Publications (1)

Sivertsen B, Knudsen AKS, Kirkoen B, Skogen JC, Lagerstrom BO, Lonning KJ, Kessler RC, Reneflot A. Prevalence of mental disorders among Norwegian college and university students: a population-based cross-sectional analysis. Lancet Reg Health Eur. 2023 Sep — View Citation

Outcome
Type Measure Description Time frame Safety issue
Primary Prevalence of mental and substance use disorders Mental and substance use disorders assessed in standardised diagnostic interviews employing the Composite International Diagnostic Interview (CIDI 5.0). Diagnostic criteria after ICD-10 and DSM-5. January 2023 to February 2023
Secondary The characteristics of nonparticipants in a psychiatric diagnostic survey Compare characteristics of participants versus nonparticipants in the survey in terms of age, gender, mental health symptoms, alcohol use, and use of health services for mental health problems. Data will be retrieved from the SHOT 2022 study, and official administrative registries and health registries. January 2023 to February 2023
See also
  Status Clinical Trial Phase
Completed NCT05660434 - Using Aromatherapy in Substance Use Disorder N/A
Active, not recruiting NCT05338268 - Substance Use and Loneliness N/A
Completed NCT04098614 - Barriers to Substance Use Disorder Recovery N/A
Completed NCT03954184 - E-health Implementation (Iowa) N/A
Completed NCT03590106 - Cardiac Surgery Peer Recovery Support Program N/A
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Recruiting NCT06273228 - Parenting Young Children in Pediatrics N/A
Recruiting NCT05327504 - Written Exposure Therapy for Veterans With SUD and PTSD N/A
Terminated NCT03517111 - The Impact of a Parenting Intervention on Latino Youth Health Behaviors N/A
Completed NCT04284813 - Families With Substance Use and Psychosis: A Pilot Study N/A
Completed NCT04401215 - Technologically-Augmented Referrals to Mitigate Addiction Consequences N/A
Not yet recruiting NCT06187701 - Co-Active Therapeutic Theatre (Co-ATT) for Dual-Diagnosis Patients N/A
Not yet recruiting NCT06163651 - Evaluating a One-Year Version of the Parent-Child Assistance Program N/A
Recruiting NCT04296604 - Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations N/A
Active, not recruiting NCT02382042 - Intensive Referral Intervention to Improve Substance Use Disorder Treatment Outcomes Among Rural and Highly Rural Veterans N/A
Terminated NCT01356667 - Drum-Assisted Therapy for Native Americans N/A
Completed NCT01237366 - Study Targeting Affect Regulation Phase 1/Phase 2
Completed NCT00708890 - Twelve Step Based Self-help Groups for Substance Related Disorders N/A
Active, not recruiting NCT04048850 - Zepatier in Patients With Substance Use
Recruiting NCT05976646 - Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion Phase 1/Phase 2